- £413.24m
- £415.30m
- £215.69m
- 72
- 76
- 83
- 94
Annual income statement for MHA, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 87.8 | 111 | 149 | 216 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 54.5 | 65.1 | 91.3 | 136 |
| Operating Profit | 33.3 | 45.7 | 58.1 | 79.4 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 32.3 | 44.9 | 58.2 | 85.9 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 31.7 | 44 | 56.3 | 83.1 |
| Net Income Before Extraordinary Items | ||||
| Net Income | 31.7 | 44 | 56.3 | 83.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 31.7 | 44 | 56.3 | 83.1 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 0.117 | 0.163 | 0.208 | 0.307 |
| Dividends per Share |